DEUTSCHE DWS SECURITIES TRUST
About this Fund
DEUTSCHE DWS SECURITIES TRUST is a renowned mutual fund company that specializes in providing a wide range of investment solutions to cater to the diverse needs of its clients, leveraging its expertise in asset management to help investors achieve their financial goals. As a trusted name in the industry, the company offers a broad spectrum of mutual funds, including equity, debt, hybrid, and money market funds, each designed to provide a unique investment strategy and risk profile. Whether investors are seeking long-term growth, regular income, or a combination of both, DEUTSCHE DWS SECURITIES TRUST has a portfolio of funds that can help them navigate the complexities of the market and make informed investment decisions. The company's focus on wealth management is evident in its commitment to providing investors with a range of options to suit their individual financial objectives, risk tolerance, and investment horizon, making it an ideal partner for those looking to create a well-diversified investment portfolio. For investors who prefer a disciplined and systematic approach to investing, DEUTSCHE DWS SECURITIES TRUST offers a systematic investment plan, or SIP, that enables them to invest a fixed amount of money at regular intervals, regardless of the market's performance, helping to reduce timing risks and avoid emotional decision-making. The company's investment philosophy is built around a rigorous research process, a strong emphasis on risk management, and a long-term perspective, which has earned it the trust of investors who value stability, consistency, and transparency in their investment experience. With a strong track record of delivering superior investment performance and a commitment to putting its clients' interests first, DEUTSCHE DWS SECURITIES TRUST has established itself as a leader in the mutual fund industry, known for its expertise in asset management, its extensive range of investment products, and its dedication to helping investors achieve their financial aspirations. By combining cutting-edge investment strategies with a deep understanding of the markets and a passion for delivering exceptional client service, DEUTSCHE DWS SECURITIES TRUST continues to be the preferred choice of investors seeking a reliable and trusted partner to manage their investments and secure their financial future. The company's investment approach is centered on a thorough understanding of the markets, a keen sense of risk management, and a relentless pursuit of excellence in every aspect of its operations, from research and portfolio construction to trade execution and customer support. This commitment to excellence has enabled DEUTSCHE DWS SECURITIES TRUST to build a loyal client base and establish long-term relationships with its investors, who appreciate the company's transparency, integrity, and unwavering dedication to their financial well-being. As a mutual fund company that is deeply invested in the success of its clients, DEUTSCHE DWS SECURITIES TRUST is constantly seeking to innovate and improve its investment products and services, staying ahead of the curve in terms of market trends, regulatory requirements, and investor expectations. By doing so, the company aims to maintain its position as a trusted leader in the mutual fund industry, a reputation that is built on its unshakeable commitment to delivering outstanding investment performance, exceptional client service, and unparalleled value to its investors.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 | 02043Q107 | Equity (Common) |
0.90%
|
$2.33 | 7,001 |
| 2 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
4.68%
|
$12.11 | 52,180 |
| 3 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
3.28%
|
$8.49 | 16,298 |
| 4 | A Agilent Technologies Inc Since 2026-05-10 | 00846U101 | Equity (Common) |
0.93%
|
$2.40 | 19,806 |
| 5 | BMRN BioMarin Pharmaceutical Inc Since 2026-05-10 | 09061G101 | Equity (Common) |
0.35%
|
$0.92 | 14,842 |
| 6 | AZN AstraZeneca PLC Since 2026-05-10 | — | Equity (Common) |
3.82%
|
$9.90 | 47,473 |
| 7 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
1.83%
|
$4.74 | 48,488 |
| 8 | ZTS Zoetis Inc Since 2026-05-10 | 98978V103 | Equity (Common) |
1.10%
|
$2.84 | 21,656 |
| 9 | RMD ResMed Inc Since 2026-05-10 | 761152107 | Equity (Common) |
0.93%
|
$2.40 | 9,347 |
| 10 | APLS Apellis Pharmaceuticals Inc Since 2026-05-10 | 03753U106 | Equity (Common) |
0.03%
|
$0.07 | 3,200 |
| 11 | BIIB Biogen Inc Since 2026-05-10 | 09062X103 | Equity (Common) |
0.83%
|
$2.14 | 11,150 |
| 12 | EYPT EyePoint Inc Since 2026-05-10 | 30233G209 | Equity (Common) |
0.15%
|
$0.39 | 21,900 |
| 13 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.79%
|
$2.04 | 11,400 |
| 14 | VEEV Veeva Systems Inc Since 2026-05-10 | 922475108 | Equity (Common) |
0.37%
|
$0.95 | 5,218 |
| 15 | NVO Novo Nordisk A/S Since 2026-05-10 | 670100205 | Equity (Common) |
1.28%
|
$3.30 | 88,210 |
| 16 | ILMN Illumina Inc Since 2026-05-10 | 452327109 | Equity (Common) |
0.24%
|
$0.63 | 4,691 |
| 17 | GMED Globus Medical Inc Since 2026-05-10 | 379577208 | Equity (Common) |
0.30%
|
$0.77 | 8,100 |
| 18 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
2.85%
|
$7.38 | 14,659 |
| 19 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
2.97%
|
$7.68 | 19,793 |
| 20 | LH Labcorp Holdings Inc Since 2026-05-10 | 504922105 | Equity (Common) |
0.39%
|
$1.01 | 3,490 |
| 21 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
2.91%
|
$7.54 | 64,801 |
| 22 | PRVA Privia Health Group Inc Since 2026-05-10 | 74276R102 | Equity (Common) |
0.38%
|
$0.98 | 41,332 |
| 23 | GEHC GE HealthCare Technologies Inc Since 2026-05-10 | 36266G107 | Equity (Common) |
0.63%
|
$1.64 | 19,500 |
| 24 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
0.70%
|
$1.81 | 24,708 |
| 25 | PFE Pfizer Inc Since 2026-05-10 | 717081103 | Equity (Common) |
1.11%
|
$2.86 | 103,470 |
| 26 | CAH Cardinal Health Inc Since 2026-05-10 | 14149Y108 | Equity (Common) |
1.50%
|
$3.87 | 16,900 |
| 27 | COR Cencora Inc Since 2026-05-10 | 03073E105 | Equity (Common) |
1.55%
|
$4.02 | 10,814 |
| 28 | RDNT RadNet Inc Since 2026-05-10 | 750491102 | Equity (Common) |
0.67%
|
$1.75 | 24,997 |
| 29 | NTRA Natera Inc Since 2026-05-10 | 632307104 | Equity (Common) |
0.36%
|
$0.94 | 4,500 |
| 30 | NBIX Neurocrine Biosciences Inc Since 2026-05-10 | 64125C109 | Equity (Common) |
0.59%
|
$1.53 | 11,537 |
| 31 | HUM Humana Inc Since 2026-05-10 | 444859102 | Equity (Common) |
0.23%
|
$0.59 | 3,116 |
| 32 | REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 | 75886F107 | Equity (Common) |
1.78%
|
$4.60 | 5,885 |
| 33 | NVS Novartis AG Since 2026-05-10 | 66987V109 | Equity (Common) |
2.91%
|
$7.54 | 44,700 |
| 34 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
4.53%
|
$11.73 | 94,719 |
| 35 | WST West Pharmaceutical Services Inc Since 2026-05-10 | 955306105 | Equity (Common) |
0.49%
|
$1.28 | 5,015 |
| 36 | IDXX IDEXX Laboratories Inc Since 2026-05-10 | 45168D104 | Equity (Common) |
0.78%
|
$2.03 | 3,089 |
| 37 | BAX Baxter International Inc Since 2026-05-10 | 071813109 | Equity (Common) |
0.22%
|
$0.56 | 27,600 |
| 38 | GILD Gilead Sciences Inc Since 2026-05-10 | 375558103 | Equity (Common) |
2.75%
|
$7.13 | 47,850 |